Abstract
Transdermal delivery offers an attractive, noninvasive administration route but it is limited by the skin’s barrier to penetration. Minimally invasive techniques, such as the use of microneedles (MNs), bypass the stratum corneum (SC) barrier to permit the drug’s direct access to the viable epidermis. These novel micro devices have been developed to puncture the skin for the transdermal delivery of hydrophilic drugs and macromolecules, including peptides, DNA and other molecules, that would otherwise have difficulty passing the outermost layer of the skin, the SC. Using the tools of the microelectronics industry, MNs have been fabricated with a range of sizes, shapes and materials. MNs have been shown to be robust enough to penetrate the skin and dramatically increase the skin permeability of several drugs. Moreover, MNs have reduced needle insertion pain and tissue trauma and provided controlled delivery across the skin. This review focuses on the current state of the art in the transdermal delivery of drugs using various types of MNs and developments in the field of microscale devices, as well as examples of their uses and clinical safety.
Keywords: Drug delivery, microneedles, safety, skin penetration enhancement, stratum corneum, transdermal delivery.
Current Drug Targets
Title:Microneedle-Based Drug Delivery Systems for Transdermal Route
Volume: 15 Issue: 3
Author(s): Maria Bernadete Riemma Pierre and Fabia Cristina Rossetti
Affiliation:
Keywords: Drug delivery, microneedles, safety, skin penetration enhancement, stratum corneum, transdermal delivery.
Abstract: Transdermal delivery offers an attractive, noninvasive administration route but it is limited by the skin’s barrier to penetration. Minimally invasive techniques, such as the use of microneedles (MNs), bypass the stratum corneum (SC) barrier to permit the drug’s direct access to the viable epidermis. These novel micro devices have been developed to puncture the skin for the transdermal delivery of hydrophilic drugs and macromolecules, including peptides, DNA and other molecules, that would otherwise have difficulty passing the outermost layer of the skin, the SC. Using the tools of the microelectronics industry, MNs have been fabricated with a range of sizes, shapes and materials. MNs have been shown to be robust enough to penetrate the skin and dramatically increase the skin permeability of several drugs. Moreover, MNs have reduced needle insertion pain and tissue trauma and provided controlled delivery across the skin. This review focuses on the current state of the art in the transdermal delivery of drugs using various types of MNs and developments in the field of microscale devices, as well as examples of their uses and clinical safety.
Export Options
About this article
Cite this article as:
Riemma Pierre Bernadete Maria and Rossetti Cristina Fabia, Microneedle-Based Drug Delivery Systems for Transdermal Route, Current Drug Targets 2014; 15 (3) . https://dx.doi.org/10.2174/13894501113146660232
DOI https://dx.doi.org/10.2174/13894501113146660232 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Controlled and Continuous Release Ocular Drug Delivery Systems: Pros and Cons
Current Drug Delivery Depression and its Relation with Uncontrolled Hypertension and Increased Cardiovascular Risk
Current Hypertension Reviews COPD Evaluation: Beyond the Airway Obstruction, a Follow Up
Current Respiratory Medicine Reviews Inducers of Heme Oxygenase-1
Current Pharmaceutical Design Editorial [Hot Topic: Ageing (Guest Editors: H.-P. Deigner and R. Kinscherf)]
Current Drug Targets An Improved Synthetic Method of Saxagliptin Intermediate 3-Hydroxy-1- acetyladamantane and Its Characterization
Letters in Organic Chemistry Patent Selections
Recent Patents on Cardiovascular Drug Discovery Mango Polyphenols and Its Protective Effects on Diseases Associated to Oxidative Stress
Current Pharmaceutical Biotechnology GPR40 Carboxylic Acid Receptor Family and Diabetes: A New Drug Target
Current Drug Targets C-20 Cyclopropyl Vitamin D3 Analogs
Current Topics in Medicinal Chemistry Potential Application of Plant-derived Bioengineered Human VEGF for Tissue Regeneration
Current Pharmaceutical Biotechnology Subject Index To Volume 5
Anti-Infective Agents in Medicinal Chemistry Immunophilins are Involved in the Altered Platelet Aggregation Observed in Patients with Type 2 Diabetes Mellitus
Current Medicinal Chemistry Clinical Significance of the New Cardiovascular Risk Markers in Diabetes Mellitus
Current Diabetes Reviews Platelet Function Testing in Atherothrombotic Disease
Current Pharmaceutical Design Lignocellulosic Biomass Derived Functional Materials: Synthesis and Applications in Biomedical Engineering
Current Medicinal Chemistry Blocking the PI3K/PKB Pathway in Tumor Cells
Current Medicinal Chemistry - Anti-Cancer Agents Aqueous Extract of Anabasis aretioides Ameliorates Streptozotocininduced Diabetes Mellitus in Rats
The Natural Products Journal Proteomics Screening of Differentially Expressed Cytokines in Tears of Patients with Graves’ Ophthalmopathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Sympathetic Mechanisms of Hypoglycemic Counterregulation
Current Diabetes Reviews